Business
ENDRA Life Sciences Strengthens Global Intellectual Property Protection with Issuance of Two European Patents Related to its TAEUS Probe
Now Has Design Protection for its Fatty Liver Imaging Probe in the U.S., China and EuropeANN ARBOR, MI / ACCESSWIRE / October 13, 2020 / ENDRA Life Sciences
About this update from Endra Life Sciences Inc.
[{"type":"text","content":"Now Has Design Protection for its Fatty Liver Imaging Probe in the U.S., China and EuropeANN ARBOR, MI / ACCESSWIRE / October 13, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), has been issued international registration certificates (patents) DM/210628 and DM/210629 by the World Intellectual Property Organization (WIPO). These patents are for proprietary designs of ENDRA's Fatty Liver Imaging Probe (FLIP) and protect ENDRA's \"Thermoacoustic Imaging Probe\" and \"Thermoacoustic Imaging Probe With Outdents.\"\"We are committed to protecting our intellectual property in key global markets and are pleased to receive these two new patents as we begin to commercialize our proprietary TAEUS technology in areas of high unmet clinical need, such as Non-Alcoholic Fatty Liver Disease (NAFLD). While NAFLD affects more than one billion people globally, there are no practical diagnostic tools especially for the early stages of disease progression,\" said Francois Michelon, ENDRA's chief executive officer.\"The recently-issued '628 and '629 patents provide more robust intellectual property (IP) protection for our TAEUS platform in a key market, Europe. In particular, the '629 certificate protects the basic appearance of the FLIP probe, including the relevant combination of shapes and surface indicia, while the '628 certificate protects a user-friendly embodiment of the '629 certificate. Our IP portfolio continues to grow and we currently have 73 patents either licensed, issued, filed or in preparation,\" he added.The parents of the '628 and '629 certificates are U.S. design patents No. USD883488S1 and USD883487S1, respectively. With the past receipt of corresponding design patents in China, ENDRA now has protection for the initial designs of its FLIP probe in all geographies where TAEUS will initially be marketed.About ENDRA Life Sciences Inc.ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), a ground-breaking technology being developed to visualize tissue like CT or MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with the over one million ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fa...